Cargando…

Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID‐19

Detalles Bibliográficos
Autores principales:	Rothlin, Rodolfo Pedro, Pelorosso, Facundo Germán, Duarte, Mariano, Nicolosi, Liliana, Ignacio, Fernandez Criado, Salgado, María Victoria, Vetulli, Héctor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086312/ https://www.ncbi.nlm.nih.gov/pubmed/37038324 http://dx.doi.org/10.1002/prp2.1083

Ejemplares similares

Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials
por: Rothlin, Rodolfo Pedro, et al.
Publicado: (2021)

Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial
por: Duarte, Mariano, et al.
Publicado: (2021)

Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
por: Hirata, Takumi, et al.
Publicado: (2013)

Erratum to “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)”
por: Hirata, Takumi, et al.
Publicado: (2014)

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome
por: Vitale, Cristiana, et al.
Publicado: (2005)

Beneficial effects of losartan or telmisartan on the local hepatic renin-angiotensin system to counter obesity in an experimental model
por: Graus-Nunes, Francielle, et al.
Publicado: (2019)

Effects of telmisartan and losartan treatments on bone turnover markers in patients with newly diagnosed stage I hypertension
por: Aydoğan, Berna İ, et al.
Publicado: (2019)

Risk of myocardial infarction, heart failure, and cerebrovascular disease with the use of valsartan, losartan, irbesartan, and telmisartan in patients
por: Yoo, Yung-Geun, et al.
Publicado: (2023)

Efficacy and Tolerability of Olmesartan, Telmisartan, and Losartan in Patients of Stage I Hypertension: A Randomized, Open-label Study
por: Kalikar, Mrunalini, et al.
Publicado: (2017)

Telmisartan, when compared to losartan, shows additional beneficial effects to pancreatic islet structure and function in diet-induced obese mice
por: Graus-Nunes, Francielle, et al.
Publicado: (2015)

Blood pressure-lowering effect of telmisartan compared to losartan among mild to moderate essential hypertensive adult subjects: A meta-analysis
por: Kumari, Kusum, et al.
Publicado: (2022)

Telmisartan and cardioprotection
por: Akhrass, Philippe R, et al.
Publicado: (2011)

Prevention and Intervention Studies with Telmisartan, Ramipril and Their Combination in Different Rat Stroke Models
por: Thoene-Reineke, Christa, et al.
Publicado: (2011)

Marking the differences in motoneurons
por: Sharples, Simon A, et al.
Publicado: (2018)

Comparative Evaluation of Enalapril and Losartan in Pharmacological Correction of Experimental Osteoporosis and Fractures of Its Background
por: Rajkumar, D. S. R., et al.
Publicado: (2013)

The Role of Losartan as a Potential Neuroregenerative Pharmacological Agent after Aneurysmal Subarachnoid Haemorrhage
por: Wanderer, Stefan, et al.
Publicado: (2020)

The pharmacological research of Tek-1 relevance to anti-neuroinflammation, a candidate compound based on Telmisartan
por: Yang, Jianbo, et al.
Publicado: (2015)

Different initiatives across Europe to enhance losartan utilization post generics: impact and implications
por: Moon, James C., et al.
Publicado: (2014)

Losartan-induced Pancreatitis
por: Anwar, Shamsuddin M, et al.
Publicado: (2019)

Efficient and improved synthesis of Telmisartan
por: Kumar, A Sanjeev, et al.
Publicado: (2010)

Telmisartan induced urticarial vasculitis
por: Mahajan, Vikram K., et al.
Publicado: (2015)

Telmisartan/hydrochlorothiazide-induced hepatotoxicity
por: Lorena, Marco, et al.
Publicado: (2015)

Telmisartan aggravates pustular psoriasis
por: Keerthi, Subramaniam, et al.
Publicado: (2015)

Is the combination of enalapril and losartan irrational?
por: Parmar, D.M., et al.
Publicado: (2008)

Impact of telmisartan in modifying vascular risk
por: Baguet, Jean-Philippe, et al.
Publicado: (2010)

A Pilot Study of Telmisartan for Visceral Adiposity in HIV Infection: The Metabolic Abnormalities, Telmisartan, and HIV Infection (MATH) Trial
por: Lake, Jordan E., et al.
Publicado: (2013)

Telmisartan Self-Nanoemulsifying Drug Delivery System, Compared With Standard Telmisartan, More Effectively Improves Hepatic Fibrosis in Rats
por: Murad, Hussam, et al.
Publicado: (2020)

Effect of Telmisartan in the Oxidative Stress Components Induced by Ischemia Reperfusion in Rats
por: Rodríguez-Lara, Simón Quetzalcoatl, et al.
Publicado: (2019)

Renovascular and renoprotective properties of telmisartan: clinical utility
por: Ladino, Marco, et al.
Publicado: (2010)

RP-HPLC Estimation of Ramipril and Telmisartan in Tablets
por: Kurade, V. P., et al.
Publicado: (2009)

Polymorphism of ORM1 Is Associated with the Pharmacokinetics of Telmisartan
por: Chen, Wang-Qing, et al.
Publicado: (2013)

Telmisartan Treatment of Refractory Proteinuria in a Dog
por: Bugbee, A.C., et al.
Publicado: (2014)

Efficacy and Safety of Azilsartan and Telmisartan in Hypertensive Patients
por: Kumar, Alok, et al.
Publicado: (2021)

Telmisartan Attenuates Kanamycin-Induced Ototoxicity in Rats
por: Lee, Chang Ho, et al.
Publicado: (2021)

Comparison of the GPVI inhibitors losartan and honokiol
por: Onselaer, Marie-Blanche, et al.
Publicado: (2019)

Difference in the effects of switching from Candesartan to Olmesartan or Telmisartan to Olmesartan in hypertensive patients with type 2 diabetes: the COTO study
por: Daikuhara, Hiroyuki, et al.
Publicado: (2014)

Effect of a fixed-dose combination of Telmisartan/S-amlodipine on circadian blood pressure compared with Telmisartan monotherapy: TENUVA-BP study
por: Kim, Bong-Joon, et al.
Publicado: (2022)

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
por: Zhang, Shuyang, et al.
Publicado: (2023)

Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects
por: Kang, Woo Youl, et al.
Publicado: (2018)

Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study
por: Higaki, Jitsuo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pj4lm4h3bbnjeqkvk0qp0ouaf3